Cullin-Ring ubiquitin ligases in kidney health and disease.


Journal

Current opinion in nephrology and hypertension
ISSN: 1473-6543
Titre abrégé: Curr Opin Nephrol Hypertens
Pays: England
ID NLM: 9303753

Informations de publication

Date de publication:
09 2019
Historique:
pubmed: 18 7 2019
medline: 30 4 2020
entrez: 18 7 2019
Statut: ppublish

Résumé

Members of the Cullin family act as scaffolds in E3 ubiquitin ligases and play a central role in mediating protein degradation. Interactions with many different substrate-binding adaptors permit Cullin-containing E3 ligases to participate in diverse cellular functions. In the kidney, one well established target of Cullin-mediated degradation is the transcription factor Nrf2, a key player in responses to oxidative stress. The goal of this review is to discuss more recent findings revealing broader roles for Cullins in the kidney. Cullin 3 acts as the scaffold in the E3 ligase regulating Nrf2 abundance, but was more recently shown to be mutated in the disease familial hyperkalemic hypertension. Studies seeking to elucidate the molecular mechanisms by which Cullin 3 mutations lead to dysregulation of renal sodium transport will be discussed. Disruption of Cullin 3 in mice unexpectedly causes polyuria and fibrotic injury suggesting it has additional roles in the kidney. We will also review recent transcriptomic data suggesting that other Cullins are also likely to play important roles in renal function. Cullins form a large and diverse family of E3 ubiquitin ligases that are likely to have many important functions in the kidney.

Identifiants

pubmed: 31313673
doi: 10.1097/MNH.0000000000000527
pmc: PMC6686897
mid: NIHMS1535392
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
CUL3 protein, human 0
Cullin Proteins 0
KLHL3 protein, human 0
Microfilament Proteins 0
NF-E2-Related Factor 2 0
NFE2L2 protein, human 0
Sodium Chloride Symporters 0
Ubiquitin-Protein Ligases EC 2.3.2.27

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

490-497

Subventions

Organisme : American Heart Association-American Stroke Association
ID : 17POST33670206
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK098141
Pays : United States
Organisme : NIDDK NIH HHS
ID : R56 DK117903
Pays : United States

Références

Int Rev Cell Mol Biol. 2016;323:181-229
pubmed: 26944622
J Diabetes Complications. 2018 Dec;32(12):1113-1117
pubmed: 30318163
Oncotarget. 2018 Dec 21;9(100):37429-37438
pubmed: 30647843
Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11908-13
pubmed: 12193649
Physiol Rep. 2016 Jul;4(13):
pubmed: 27378813
Invest New Drugs. 2016 Aug;34(4):439-49
pubmed: 27056178
Science. 2001 Aug 10;293(5532):1107-12
pubmed: 11498583
Oncogene. 2019 Feb;38(7):1038-1049
pubmed: 30194449
J Biol Chem. 2006 Oct 27;281(43):32188-96
pubmed: 16943200
Free Radic Biol Med. 2015 Sep;86:374-81
pubmed: 25930007
Cell Metab. 2015 Jan 6;21(1):39-50
pubmed: 25565204
Biochem Biophys Res Commun. 2017 May 27;487(2):368-374
pubmed: 28414128
J Biol Chem. 2014 May 9;289(19):13347-61
pubmed: 24668812
Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15556-61
pubmed: 25313067
Mol Cell Biol. 2007 May;27(10):3651-66
pubmed: 17339333
Am J Physiol Renal Physiol. 2018 Oct 1;315(4):F781-F790
pubmed: 29412704
Annu Rev Physiol. 2016;78:367-89
pubmed: 26863326
Cancer Cell. 2018 Jul 9;34(1):21-43
pubmed: 29731393
Toxicol Appl Pharmacol. 2018 Dec 1;360:30-37
pubmed: 30248418
N Engl J Med. 2016 Jan 14;374(2):135-45
pubmed: 26536169
Mol Cell Biol. 2017 Mar 17;37(7):
pubmed: 28052936
J Clin Invest. 2014 Nov;124(11):4723-36
pubmed: 25250572
Nat Med. 2017 Jul;23(7):869-877
pubmed: 28553932
N Engl J Med. 2013 Dec 26;369(26):2492-503
pubmed: 24206459
J Am Soc Nephrol. 2018 Nov;29(11):2627-2640
pubmed: 30301860
FEBS Lett. 2015 Sep 14;589(19 Pt A):2507-13
pubmed: 26096786
Exp Cell Res. 2008 Nov 15;314(19):3453-65
pubmed: 18835386
Genes Dev. 2005 Jul 1;19(13):1518-31
pubmed: 15961524
Genes Dev. 1999 Sep 15;13(18):2375-87
pubmed: 10500095
Clin Exp Nephrol. 2018 Dec;22(6):1251-1257
pubmed: 29869755
J Biol Chem. 2005 Aug 26;280(34):30091-9
pubmed: 15983046
Nature. 2012 Jan 22;482(7383):98-102
pubmed: 22266938
Science. 2018 May 18;360(6390):758-763
pubmed: 29622724
J Hepatol. 2014 Sep;61(3):617-25
pubmed: 24815875
Int J Biochem Cell Biol. 2013 Jul;45(7):1327-37
pubmed: 23583660
Am J Nephrol. 2018;47(1):40-47
pubmed: 29402767
EMBO Mol Med. 2015 Aug 18;7(10):1285-306
pubmed: 26286618
Cell Rep. 2013 Mar 28;3(3):858-68
pubmed: 23453970
Kidney Int. 2017 Feb;91(2):402-411
pubmed: 28341239
Exp Mol Med. 2018 Apr 13;50(4):30
pubmed: 29651023
Sci Rep. 2019 Mar 14;9(1):4596
pubmed: 30872636
Diabetes. 2012 Dec;61(12):3208-18
pubmed: 22936178
BMC Nephrol. 2016 Aug 02;17(1):110
pubmed: 27484495
Free Radic Biol Med. 2019 Apr;134:9-22
pubmed: 30599261
J Biol Chem. 2015 Jul 31;290(31):19208-17
pubmed: 26100637
JCI Insight. 2017 Dec 21;2(24):
pubmed: 29263298
Nat Cell Biol. 2005 Apr;7(4):387-91
pubmed: 15793566
J Am Soc Nephrol. 2019 May;30(5):782-794
pubmed: 30914436
Biochem Biophys Res Commun. 2013 Aug 2;437(3):457-62
pubmed: 23838290
Proc Natl Acad Sci U S A. 2019 Feb 19;116(8):3155-3160
pubmed: 30718414
J Am Soc Nephrol. 2019 Jan;30(1):23-32
pubmed: 30510133
Blood Cancer J. 2017 Feb 3;7(2):e520
pubmed: 28157218
BMC Biochem. 2006 Jan 09;7:1
pubmed: 16401342
JCI Insight. 2016 Nov 17;1(19):e91015
pubmed: 27882355
Kidney Int. 2016 Jan;89(1):127-34
pubmed: 26422504
Nat Genet. 2012 Mar 11;44(4):456-60, S1-3
pubmed: 22406640
Am J Physiol Renal Physiol. 2018 Oct 1;315(4):F1006-F1018
pubmed: 29897280
Am J Physiol Renal Physiol. 2018 May 1;314(5):F915-F920
pubmed: 29361671
Kidney Int. 2009 Nov;76(9):939-45
pubmed: 19657325
Proc Natl Acad Sci U S A. 2013 May 7;110(19):7838-43
pubmed: 23576762
Am J Physiol Renal Physiol. 2009 Aug;297(2):F461-70
pubmed: 19458120
J Am Soc Nephrol. 2015 Nov;26(11):2669-77
pubmed: 25817355

Auteurs

Ryan J Cornelius (RJ)

Division of Nephrology and Hypertension, Department of Medicine, Oregon Health & Science University, Portland, Oregon, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH